Search Results - "Patai, Á."

Risk prediction model for developing pancreatic necrosis by Kiss, S., Farkas, N., Fehérvári, P., Pecze, L., Szakó, L., Vincze, Á., Gódi, S., Bajor, J., Czimmer, J., Sarlós, P., Hágendorn, R., Takács, T., Izbéki, F., Halász, A., Hamvas, J., Varga, M., Crai, S., Mickevicius, A., Patai, Á., Ihász, M., Varjú, P., Faluhelyi, N., Farkas, O., Miseta, A., Kelemen, D., Papp, R., Hegyi, P.J., Szentesi, A., Párniczky, A., Hegyi, P.

Get full text

P164 Free DNA level in patients with inflammatory bowel diseases by Miheller, P., Lorinczy, K., Patai, Á., Csontos, A., Galamb, O., Molnár, B., Tulassay, Z.

Get full text

P661 Ustekinumab in Crohn’s disease: A three-year multicentre prospective study from Hungary - Assessing efficacy, drug sustainability, and safety by Barkai, L J, Gonczi, L, Farkas, K, Farkas, B, Molnar, T, Szamosi, T, Schafer, E, Golovics, P, Juhasz, M, Patai, A, Vincze, A, Sarlos, P, Farkas, A, Dubravcsik, Z, Toth, T G, Miheller, P, Lakatos, P L, Ilias, A

“…Abstract Background While randomized controlled trials have shown ustekinumab (UST) as an effective therapeutic option for Crohn’s disease (CD), there is a…”
Get full text

P441 Clinical efficacy, drug sustainability and results from therapeutic drug monitoring in Crohn’s disease patients treated with ustekinumab – 1-year follow-up of a prospective, nationwide, multicenter cohort from Hungary by Gonczi, L, Szanto, K, Farkas, K, Molnar, T, Szamosi, T, Schafer, E, Golovics, P, Lovasz, B, Patai, A, Vincze, A, Sarlos, P, Farkas, A, Dubrovcsik, Z, Tóth G, T, Lakatos, P L, Miheller, P, Ilias, A

“…Abstract Background Although efficacy and safety of ustekinumab (UST) in the treatment of inflammatory bowel disease have been demonstrated through randomized…”
Get full text

DOP37 Large differences in IBD care and education across Europe, first results of the pan-European VIPER survey by Král, J, Nakov, R, Lanska, V, Barberio, B, Benech, N, Blesl, A, Brunet, E, Capela, T L, Derikx, L A A P, Dragoni, G, Eek, A, Frias-Gomes, C, Gîlcă-Blanariu, G E, Gilroy, L, Harvey, P R, Kagramanova, A, Kani, H T, Konikoff, T, Lessing, M, Madsen, G R, Maksimaityte, V, Miasnikova, M, Mikolasevic, I, Milivojevic, V, Noviello, D, Oliinyk, D, Patai, A, Protopapas, A A, Rodríguez-Lago, I, Schreiber, P, Skuja, V, Tran, F, Truyens, M, Włodarczyk, M, Zatorski, H, Verstockt, B, Segal, J P

“…Abstract Background More than 2.5 million people in Europe suffer from inflammatory bowel diseases (IBD). IBD affects the quality of life, but also has…”
Get full text

PO-384 Manual and automated detection of DNA methylation alterations in colorectal neoplasia in circulating cell-free DNA fraction by Bartak, B.K., Kalmar, A., Patai, A., Galamb, O., Valcz, G., Wichmann, B., Nagy, Z.B., Tulassay, Z., Igaz, P., Molnar, B.

“…During colorectal cancer (CRC) development several epigenetic changes, including DNA methylation in the promoter regions accumulate in tumour cells that can be…”
Get full text

P592 Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort by Lovasz, B.D., Kurti, Z., Rutka, M., Vegh, Z., Gecse, K.B., Farkas, K., Banai, J., Bene, L., Golovics, P.A., Gonczi, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Palatka, K., Patai, A., Papp, M., Salamon, A., Szamosi, T., Szepes, Z., Toth, G.T., Vincze, A., Szalay, B., Molnar, T., Lakatos, P.L.

Get full text

P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort by Gecse, K.B., Vegh, Z., Kurti, Z., Rutka, M., Farkas, K., Golovics, P.A., Lovasz, B.D., Gonczi, L., Banai, J., Bene, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Nagy, F., Palatka, K., Papp, M., Patai, A., Salamon, A., Szamosi, T., Szepes, Z., Toth, G.T., Vincze, A., Molnar, T., Lakatos, P.L.

Get full text

Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials by Patai, Árpád V, Solymosi, Norbert, Mohácsi, László, Patai, Árpád

Get full text

Endoscopic treatment of cholestasis caused by Ascaris lumbricoides by Vizer, G, Patai, A, Döbrönte, Z

“…The most common infection of the hepatobiliary system and of the pancreas is the infestation with Ascaris lumbricoides. Pancreatobiliary ascariasis may present…”
Get more information

Palliative treatment of large bile duct stones by endoscopic implantation of endoprosthesis in high risk patients by Döbrönte, Z, Patai, A

“…Endoscopic insertion of biliary stents is an established method in the palliative treatment of malignant bile duct stenoses. However, there is less experience…”
Get more information

Efficiency of electro-hydrothermal coagulation in the management of non-variceal upper gastrointestinal bleeding by Patai, A, Jakab, Z, Nádasi, G, Márkus, B, Döbrönte, Z

“…The data of 596 electro-hydrothermal coagulations in nonvariceal acute gastrointestinal bleeding were retrospectively evaluated and the results were compared…”
Get more information

Sinoatrial block caused by gastroesophageal reflux. The role of simultaneous 24 hr. esophageal pH-metry and Holter-ECG in the differential diagnosis of angina pectoris by Patai, A, Sipos, E, Döbrönte, Z

“…The authors report on a 61-year-old female patient, who has suffered from recurrent angina-like chest pain for 30 years. The patient's complaints became…”
Get more information

Management of Oddi sphincter dyskinesis. Results of drug therapy and sphincterotomy by Döbrönte, Z, Simon, L, Patai, A

“…In a retrospective evaluation, the outcome of the long term treatment of the sphincter of Oddi dyskinesia (OD, type III. dysfunction) has been analysed…”
Get more information

Management of hypertensive dyskinesia of Oddi's sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct by Simon, L, Döbrönte, Z, Patai, A

“…to evaluate the treatment possibilities in different forms of sphincter of Oddi dysfunction (SOD), in particularly that of the hypertonic sphincter of Oddi…”
Get more information

Epidemiology of non-variceal upper gastrointestinal hemorrhage in Vas County in Western Hungary by Patai, A, Jakab, Z, Varga, F, Drácz, L, Rakonczai, E, Döbrönte, Z

“…Data of 3014 patients with nonvariceal upper gastrointestinal bleeding were retrospectively evaluated in county Vas between 1984 and 1995. The annual incidence…”
Get more information

Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology by Patai, A, Héber, S, Döbrönte, Z, Kovács, L G

“…The diagnostic values of CA 19-9 and CEA were evaluated in 187 cases (including 31 gastric, 41 colorectal, 12 pancreatic, 7 hepatobiliar and 5 hepatocellular…”
Get more information